Article

Protection from viral rebound after therapeutic vaccination with an adjuvanted DNA vaccine…

medRxiv · 2020 · Hillary C. Tunggal

Key facts

Title Protection from viral rebound after therapeutic vaccination with an adjuvanted DNA vaccine is associated with SIV-specific polyfunctional CD8 T cells in the blood and mesenteric lymph nodes
First author Hillary C. Tunggal
Journal medRxiv
Published Sep 16, 2020
DOI 10.1101/2020.09.16.299511
Devices mentioned BK110039, K073490, K883302
Product codes mentioned CFN, JJQ, PCA, KIT, MVU

At a glance

  • 1–9 FDA submissions mentioned
  • 1–9 Product codes mentioned

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About Literature

Peer-reviewed and preprint literature indexed by Orca1 and linked to the FDA submissions and product codes each article mentions. Only bibliographic details are shown here.

Source: Publisher and PubMed metadata; device mentions identified by Orca1

Browse all Literature